Whether medicinal marijuana should be legalised has attracted debate recently. Central to the discussion both in New Zealand and overseas, is how legalising the drug for medicinal purposes will affect the use of non-medical ...
Jul 6, 2016
5
85
Cornell and New York state scientists estimate that some gardeners who toil in urban gardens and children who play in them could be exposed to lead levels that exceed U.S Food and Drug Administration thresholds. Their new ...
Apr 8, 2016
0
6
Two studies carried out by US researchers and published by The BMJ today raise questions about whether most new drugs are any more effective than existing products or whether they have been adequately assessed before approval.
Sep 23, 2015
0
15
The high price of two new anti-cholesterol drugs limits the benefits patients may see from them, according to a draft report released Wednesday by a US nonprofit examining drug cost effectiveness.
Sep 9, 2015
0
4
The Food and Drug Administration released its proposal Thursday for naming lower-cost biotech drugs, a critical step in creating a market for the new class of medicines.
Aug 27, 2015
0
5
Drugmaker GlaxoSmithKline shut down a plant Tuesday that produces inhaled medications after discovering the bacteria that causes Legionnaire's disease, a potentially fatal form of pneumonia.
Aug 11, 2015
0
6
For the second time this year, the House used overwhelming bipartisan unity Friday to approve health legislation, this time voting to bolster biomedical research and streamline how the government approves drugs and medical ...
Jul 10, 2015
0
7
US experts urged regulators Wednesday to approve a second new anti-cholesterol drug, a day after recommending they bring to market the first in a new class of medications to lower the risk of heart attack.
Jun 10, 2015
0
11
Federal health regulators said Monday a highly-anticipated, experimental drug from Amgen significantly lowers bad cholesterol. But officials have questions about who should take the drug and whether to approve it based on ...
Jun 8, 2015
0
3
The U.S. Food and Drug Administration must hold companies to a higher standard when it comes to herbal supplements, said Edward Bednarczyk, University at Buffalo pharmacy practice chair, PharmD.
Apr 8, 2015
0
28
